Cybersecurity Concerns Grow As US FDA Sees Increasing Device Vulnerabilities
This article was originally published in SRA
Executive Summary
Concerns about cybersecurity threats to medical devices have grown over the past year and half, the US Food and Drug Administration affirms, as more and more wireless medical devices have been found to have potential vulnerabilities that hackers could take advantage of and endanger patients.
You may also be interested in...
Lawmakers Question FDA On Medical Device Cybersecurity Concerns
Top lawmakers on the House Energy and Commerce Committee wrote to US FDA asking what the agency is doing to ensure devices are protected against malicious hackers.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.